IGF2BP1 and hepatocellular carcinoma: Cucurbitacin B has been demonstrated to inhibit the binding of IGF2BP1 to m6A-modified mRNA and increase immune cell infiltration, suggesting that it is a potential anti-HCC agent (Figure 4) (121).